Skip to main content
. Author manuscript; available in PMC: 2008 Feb 25.
Published in final edited form as: Eur J Drug Metab Pharmacokinet. 2001 Oct–Dec;26(4):235–240. doi: 10.1007/BF03226377

Fig. 3.

Fig. 3

Effect of potential cytochrome P450 inhibitors on the metabolic formation of indoxyl using rat liver microsomes. Bars represent the mean ± SD of two determinations, and 100% activity represents activity in the absence of inhibitor (325 pmol min−1 mg−1). SKF 525-A, 2-diethyl-aminoethyl-2,2-diphenylvalerate; DDTC, diethyldithiocarbamic acid.